Britain/B-GPE 's/O Monopolies/B-ORG and/I-ORG Mergers/I-ORG Commission/I-ORG Wednesday/O cleared/O Rhone/B-ORG -/I-ORG Poulenc/I-ORG S.A./I-ORG 's/I-ORG purchase/O of/O a/O specialty/O bulk/O -/O chemical/O unit/O from/O Monsanto/B-ORG Co./I-ORG ,/O saying/O the/O purchase/O was/O unlikely/O to/O have/O any/O lasting/O impact/O on/O U.K./B-GPE industrial/O consumers/O ./O
The/O commission/O ,/O which/O was/O asked/O to/O study/O the/O deal/O by/O the/B-ORG Department/I-ORG of/I-ORG Trade/I-ORG and/I-ORG Industry/I-ORG after/O its/O announcement/O in/O February/O ,/O said/O the/O diversity/O of/O global/O supply/O of/O chemicals/O used/O in/O making/O analgesic/O drugs/O was/O great/O enough/O to/O offset/O the/O dominant/O U.K./B-GPE market/O share/O Rhone/B-ORG -/I-ORG Poulenc/I-ORG would/O gain/O through/O the/O acquisition/O ./O
The/O French/O chemical/O giant/O would/O hold/O an/O 80/O %/O share/O of/O the/O U.K./B-GPE market/O for/O salicylic/O acid/O ,/O methyl/O salicylate/O and/O bulk/O aspirin/O ./O
The/O commission/O found/O that/O if/O the/O British/O government/O attempted/O to/O block/O the/O merger/O ,/O Rhone/B-ORG -/I-ORG Poulenc/I-ORG would/O likely/O respond/O by/O closing/O the/O salicylates/O plant/O Monsanto/B-ORG operates/O in/O Wales/B-GPE ,/O removing/O the/O matter/O from/O U.K./B-GPE jurisdiction/O ./O
